327 related articles for article (PubMed ID: 27388261)
1. From current status to optimization of HCV treatment: Recommendations from an expert panel.
Craxì A; Perno CF; Viganò M; Ceccherini-Silberstein F; Petta S;
Dig Liver Dis; 2016 Sep; 48(9):995-1005. PubMed ID: 27388261
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel.
Viganò M; Perno CF; Craxì A;
Dig Liver Dis; 2017 Jul; 49(7):731-741. PubMed ID: 28456519
[TBL] [Abstract][Full Text] [Related]
3. The impact of hepatitis C virus outside the liver: Evidence from Asia.
Younossi ZM; Tanaka A; Eguchi Y; Lim YS; Yu ML; Kawada N; Dan YY; Brooks-Rooney C; Negro F; Mondelli MU
Liver Int; 2017 Feb; 37(2):159-172. PubMed ID: 27748564
[TBL] [Abstract][Full Text] [Related]
4. Real life experiences in HCV management in 2018.
Viganò M; Andreoni M; Perno CF; Craxì A; Aghemo A; Alberti A; Andreone P; Babudieri S; Bonora S; Brunetto MR; Bruno R; Bruno S; Calvaruso V; Caporaso N; Cartabellotta F; Ceccherini-Silberstein F; Cento V; Ciancio A; Colombatto P; Coppola N; Di Marco V; Di Perri G; Fagiuoli S; Gaeta GB; Gasbarrini A; Lampertico P; Pellicelli A; Prestileo T; Puoti M; Raimondo G; Rizzardini G; Taliani G; Zignego AL
Expert Rev Anti Infect Ther; 2019 Feb; 17(2):117-128. PubMed ID: 30582384
[TBL] [Abstract][Full Text] [Related]
5. Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.
Nasta P; Maida I; Cattelan AM; Pontali E; Angeli E; Giralda M; Verucchi G; Caputo A; Iannacone C; Puoti M; Carosi G
J Womens Health (Larchmt); 2015 Feb; 24(2):159-64. PubMed ID: 25682817
[TBL] [Abstract][Full Text] [Related]
6. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
Michielsen P; Ho E; Francque S
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
[TBL] [Abstract][Full Text] [Related]
7. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK;
Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285
[TBL] [Abstract][Full Text] [Related]
8. A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin.
Selvapatt N; Habibi MS; Brown A
J Med Virol; 2015 Oct; 87(10):1716-21. PubMed ID: 25914248
[TBL] [Abstract][Full Text] [Related]
9. Update on hepatitis C: epidemiology, treatment and resistance to antiviral therapies.
Ness E; Kowdley KV
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):145-58. PubMed ID: 25990619
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C: treat everyone now or stratify by disease?
Reiberger T
Minerva Gastroenterol Dietol; 2015 Mar; 61(1):11-9. PubMed ID: 25356568
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of interferon-based therapy for chronic hepatitis C.
Yu ML; Huang CF; Dai CY; Huang JF; Chuang WL
Oncology; 2007; 72 Suppl 1():16-23. PubMed ID: 18087178
[TBL] [Abstract][Full Text] [Related]
12. Assessment of factors affecting response of direct-acting antivirals in chronic hepatitis C patients.
Jain N; Garg R; Singh GP; Kaur S; Chawla SPS; Padda P
Ann Afr Med; 2023; 22(4):456-464. PubMed ID: 38358146
[TBL] [Abstract][Full Text] [Related]
13. A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Braun DL; Rauch A; Aouri M; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Müllhaupt B; Metzner KJ; Decosterd L; Böni J; Weber R; Fehr J;
PLoS One; 2015; 10(7):e0133028. PubMed ID: 26176696
[TBL] [Abstract][Full Text] [Related]
14. Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C.
Jung CH; Um SH; Kim TH; Yim SY; Suh SJ; Yim HJ; Seo YS; Choi HS; Chun HJ
Gut Liver; 2016 Sep; 10(5):808-17. PubMed ID: 27114417
[TBL] [Abstract][Full Text] [Related]
15. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
16. Predicted effects of treatment for HCV infection vary among European countries.
Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P
Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764
[TBL] [Abstract][Full Text] [Related]
17. 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.
European Association of the Study of the Liver
Liver Int; 2012 Feb; 32 Suppl 1():2-8. PubMed ID: 22212565
[TBL] [Abstract][Full Text] [Related]
18. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.
Béguelin C; Suter A; Bernasconi E; Fehr J; Kovari H; Bucher HC; Stoeckle M; Cavassini M; Rougemont M; Schmid P; Wandeler G; Rauch A;
Liver Int; 2018 Mar; 38(3):424-431. PubMed ID: 28741901
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
Kovari H; Russmann S; Ledergerber B; Müller D; Rotger M; Velli P; Cavassini M; Ambrosioni J; Bregenzer A; Stöckle M; Bernasconi E; Rauch A; Speck RF;
PLoS One; 2015; 10(7):e0133879. PubMed ID: 26218843
[TBL] [Abstract][Full Text] [Related]
20. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
